8-K
Current Report
Aclaris Therapeutics, Inc. Filed Acc 0001104659-23-024751
Material agreement · Agreement ended
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading tm237408d1_8k.htm…